“The new members bring a wealth of knowledge in treating diabetes patients and they will be important advocates for the use of the PromarkerD test. We look forward to working with them as we bring PromarkerD to patients across the United States” Proteomics International Managing Director Dr Richard Lipscombe
Article: Proteomics boosts kidney test prospects with board gains